Today's Hours: 8:00am - 6:00pm

Search

Filter Applied Clear All

Did You Mean:

Search Results

  • Book
    Tom Brody.
    Contents:
    1. Origins of drugs
    2. Clinical trial design
    3. Run-in period
    4. Inclusion/exclusion criteria, stratification, and subgroups
    part I
    5. Inclusion/exclusion criteria, stratification, and subgroups
    part II
    6. Blinding, randomization, and allocation
    7. Placebo arm as part of clinical trial design
    8. Intent-to-treat analysis versus per protocol analysis
    9. Biostatistics
    part I
    10. Biostatistics
    part II
    11. Introduction to endpoints
    12. Oncology endpoint
    objective response
    13. Oncology endpoints : overall survival and progression-free survival
    14. Oncology endpoints : time to progression
    15. Oncology endpoint : disease-free survival
    16. Oncology endpoint : time to distant metastasis
    17. Neoadjuvant therapy versus adjuvant therapy
    18. Hematological cancers
    19. Biomarkers
    20. Endpoints for immune diseases
    21. Endpoints for infections
    22. Health-related quality of life tools
    oncology
    23. Health-related quality-of-life tools
    immune disorders
    24. Health-related quality-of-life tools
    infections
    25. Drug safety
    26. Mechanism of action of diseases and drugs
    part I
    27. Mechanism of action
    part II (cancer)
    28. Mechanism of action
    part III (immune disorders)
    29. Mechanisms of action
    part IV (infections)
    30. Consent forms
    31. Package inserts
    32. Warning letters
    33. Regulatory approval
    34. Patents.
    Digital Access ClinicalKey 2016